PharmaceuticalCompanies
List your company
Menu
Register entry

Formosa Laboratories, Inc.

Data as of · How to read this entry

Request a quoteClaim this profile
Registered sites
1
Active NDC listings
33
Live patents
0
Countries
1
Base
Taiwan
Authorisation

Registered operations

Analytical testing1Active ingredient (API) manufacture1Labelling1Finished drug manufacture1Packaging1
Sites

Registered establishments

1
EstablishmentAddressRegistered forFEI / DUNS
Formosa Laboratories, Inc.36 Heping St., Luzhu Dist., Taoyuan, 338002, Taiwan (TWN)Analytical testing, Active ingredient (API) manufacture, Labelling, Finished drug manufacture, Packaging3003420376657846858
Catalogue

Drug listings by form and route

33

33 active NDC listings: 33 bulk ingredient. By marketing category: BULK INGREDIENT 33.

Dosage formNDCs
powder32
liquid1
RouteNDCs
Labeller name on the listingNDCs
formosa laboratories, inc.33
Catalogue

Marketed products

33
BrandGeneric nameForm / routeNDC
-Balsalazide Disodium Dihydratepowder66499-0004BULK INGREDIENT
-Benzonatateliquid66499-0068BULK INGREDIENT
-Calcipotriol Anhydrouspowder66499-0005BULK INGREDIENT
-Calcipotriol Monohydratepowder66499-0024BULK INGREDIENT
-Calcitriolpowder66499-0003BULK INGREDIENT
-Capsaicinpowder66499-0036BULK INGREDIENT
-Colesevelam Hydrochloridepowder66499-0022BULK INGREDIENT
-Colestipol Hydrochloridepowder66499-0007BULK INGREDIENT
-Dinalbuphine Sebacatepowder66499-0060BULK INGREDIENT
-Doxercalciferolpowder66499-0011BULK INGREDIENT
-Elagolix Sodiumpowder66499-0072BULK INGREDIENT
-Ergocalciferolpowder66499-0041BULK INGREDIENT
-Eribulin Mesylatepowder66499-0074BULK INGREDIENT
-Gadoterate Megluminepowder66499-0066BULK INGREDIENT
-Iloperidonepowder66499-0042BULK INGREDIENT
-Iloperidonepowder66499-0067BULK INGREDIENT
-Leflunomidepowder66499-0001BULK INGREDIENT
-Levonorgestrelpowder66499-0018BULK INGREDIENT
-Linezolidpowder66499-0047BULK INGREDIENT
-Mifepristonepowder66499-0056BULK INGREDIENT
-Mycophenolate Mofetilpowder66499-0006BULK INGREDIENT
-Mycophenolate Sodiumpowder66499-0039BULK INGREDIENT
-Nintedanibpowder66499-0061BULK INGREDIENT
-Nintedanib Esylatepowder66499-0062BULK INGREDIENT
-Paricalcitolpowder66499-0019BULK INGREDIENT
-Patiromer Sorbitex Calciumpowder66499-0063BULK INGREDIENT
-Pazopanib Hydrochloridepowder66499-0055BULK INGREDIENT
-Sevelamer Carbonatepowder66499-0023BULK INGREDIENT
-Sevelamer Hydrochloridepowder66499-0020BULK INGREDIENT
-Tasimelteonpowder66499-0054BULK INGREDIENT
-Temozolomidepowder66499-0015BULK INGREDIENT
-Teriflunomidepowder66499-0059BULK INGREDIENT
-XAV-939powder66499-0080BULK INGREDIENT
Compare

Comparable companies in Taiwan

Enquiry

Common questions

Is Formosa Laboratories, Inc. FDA approved?
Formosa Laboratories, Inc. holds 1 FDA-registered establishment in Taiwan. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Formosa Laboratories, Inc.'s drugs manufactured?
The FDA register lists Taoyuan. Registered operations: analytical testing, active ingredient (API) manufacture, labelling, finished drug manufacture, packaging.
What drugs does Formosa Laboratories, Inc. make?
33 products are listed under Formosa Laboratories, Inc. in the openFDA NDC Directory, most often as powder; liquid. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.